Cardlytics (NASDAQ:CDLX) Trading 3.3% Higher – Here’s What Happened

Cardlytics, Inc. (NASDAQ:CDLX)’s stock price was up 3.3% during trading on Thursday . The company traded as high as $0.9132 and last traded at $0.8649. Approximately 541,740 shares were traded during mid-day trading, a decline of 30% from the average daily volume of 768,704 shares. The stock had previously closed at $0.8371.

Wall Street Analyst Weigh In

Several research analysts have recently commented on the company. Weiss Ratings reiterated a “sell (d-)” rating on shares of Cardlytics in a research report on Monday, December 29th. Wall Street Zen cut Cardlytics from a “hold” rating to a “sell” rating in a research note on Saturday, November 8th. Three investment analysts have rated the stock with a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Reduce” and a consensus target price of $2.25.

Cardlytics Stock Performance

The company has a market capitalization of $46.76 million, a price-to-earnings ratio of -0.41, a P/E/G ratio of 0.13 and a beta of 1.03. The stock has a 50 day simple moving average of $1.14 and a 200 day simple moving average of $1.50. The company has a quick ratio of 1.14, a current ratio of 1.14 and a debt-to-equity ratio of 2.87.

Cardlytics (NASDAQ:CDLX) last announced its quarterly earnings results on Wednesday, November 5th. The company reported ($0.07) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.15) by $0.08. Cardlytics had a negative return on equity of 235.70% and a negative net margin of 44.12%.The business had revenue of $52.03 million for the quarter, compared to analysts’ expectations of $56.64 million. As a group, analysts anticipate that Cardlytics, Inc. will post -1.52 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Cardlytics

Several institutional investors have recently modified their holdings of the company. Vanguard Personalized Indexing Management LLC acquired a new stake in Cardlytics during the 3rd quarter worth about $26,000. Check Capital Management Inc. CA lifted its position in shares of Cardlytics by 20.7% in the second quarter. Check Capital Management Inc. CA now owns 74,500 shares of the company’s stock worth $123,000 after purchasing an additional 12,800 shares in the last quarter. Global Retirement Partners LLC boosted its holdings in shares of Cardlytics by 67.3% during the third quarter. Global Retirement Partners LLC now owns 34,800 shares of the company’s stock worth $85,000 after purchasing an additional 14,000 shares during the period. Brooktree Capital Management grew its position in Cardlytics by 8.3% during the second quarter. Brooktree Capital Management now owns 242,249 shares of the company’s stock valued at $398,000 after purchasing an additional 18,624 shares in the last quarter. Finally, Catalyst Funds Management Pty Ltd purchased a new position in Cardlytics during the second quarter valued at approximately $32,000. Institutional investors own 68.10% of the company’s stock.

Cardlytics Company Profile

Cardlytics, Inc operates a purchase intelligence and marketing platform that connects advertisers with consumers through bank and credit card transaction data. The company partners with financial institutions to analyze anonymized purchase information, enabling brands to deliver highly targeted offers and rewards directly to customers’ online and mobile banking channels. By leveraging real-time insights into consumer spending habits, Cardlytics helps marketers optimize campaign performance and measure return on ad spend more accurately than traditional digital advertising methods.

At the core of Cardlytics’ offering is its proprietary purchase intelligence engine, which aggregates and anonymizes transaction data from partner banks and credit unions.